Nurix

Scientist, Bioanalytical - Drug Antibody Conjugates (DACs)

Nurix$120K — $145K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. with 5+ years or M.S. with 8+ years of relevant industry experience in Bioanalysis or Analytical Chemistry.
  • Deep expertise in LC-MS/MS bioanalysis, method development, qualification, and troubleshooting for complex modalities.
  • Proven experience with Sciex platforms, specifically 7600 ZenoTOF and 6500+ series.
  • Strong background in antibody-drug conjugates (ADCs), degrader antibody conjugates (DACs) or related bioconjugates.
  • Familiarity with in vitro ADME and in vivo PK studies, with proven data interpretation skills.

Responsibilities

  • Lead bioanalytical method development and execution for DAC modalities in biological matrices.
  • Design and implement LC-MS/MS workflows for quantitation of small molecule payloads and related species.
  • Apply high-resolution mass spectrometry for characterization and metabolite identification of DACs.
  • Develop hybrid assays to enhance quantitation accuracy and molecular distinctions.
  • Conduct in vitro studies for stability and degradation kinetics analysis.
  • Manage bioanalytical support for in vivo PK studies and tissue distribution assessment.
  • Characterize biotransformation pathways of DACs and identify modifications.

Benefits

  • Mentorship opportunities for junior scientists to build capabilities.
  • Collaborative work environment with interdisciplinary teams.
  • Potential access to emerging technologies and innovative approaches.
  • Opportunity to contribute to the development of cutting-edge therapeutic modalities.
Full Job Description
Position

Nurix Therapeutics is seeking a Scientist to lead bioanalytical strategies supporting the discovery and development of next-generation degrader antibody conjugates (DACs). This role will focus on LC-MS/MS and hybrid assay strategies for quantitative and qualitative analysis of complex bioconjugates across in vitro and in vivo studies to understand DAC pharmacokinetics, pharmacodynamics, and biotransformation.

The successful candidate will operate at the interface of small and large molecule bioanalysis, and will contribute to assay development, method qualification, and execution, applying advanced LC-MS/MS and hybrid approaches to support in vitro and in vivo studies across discovery and early development

Key Responsibilities
  • Lead the development, qualification, and execution of bioanalytical methods for DAC modalities, including intact conjugates, total antibody, conjugated payload, and released degrader species in complex biological matrices.
  • Design and implement LC-MS/MS-based workflows using Sciex platforms for sensitive and selective quantitation of small molecule payloads, linker-derived species, and catabolites
  • Apply high-resolution mass spectrometry platforms for DAC characterization and metabolite identification
  • Develop hybrid LBA-LC-MS/MS strategies to address challenges in conjugate quantitation and differentiation of molecular species.
  • Design, execute and interpret in vitro studies, including plasma and lysosomal stability, linker cleavage kinetics, protease-mediated processing, and degradation assays.
  • Lead bioanalytical support for in vivo studies, including PK, tissue distribution, and tumor exposure in preclinical species integrating DAC components to inform exposure-response relationships.
  • Characterize biotransformation pathways of DACs, including identification of linker cleavage products, payload metabolites, and antibody modifications.
  • Partner closely with DMPK, Proteomics, Pharmacology and Chemistry teams to inform molecular design through data-driven insights on stability, exposure, and degradation efficiency.
  • Author and review technical reports, regulatory documentation, and study summaries with a high level of scientific rigor and clarity.
  • Troubleshoot analytical challenges related to matrix effects, low-level quantitation, and conjugate heterogeneity.
  • Mentor junior scientists and contribute to building bioanalytical capabilities and best practices within the organization.
  • Evaluate and implement emerging technologies to advance characterization of targeted protein degrader modalities.
  • Lead the identification, selection, and oversight of contract research organizations (CROs) for bioanalytical method development, assay transfer, and phase-appropriate qualification.

Preferred Qualifications & Experience
  • Experience in targeted protein degradation or heterobifunctional degrader platforms.
  • Experience with hybrid LBA-LC-MS/MS assays and ligand-binding assays (ELISA, MSD).
  • Understanding of linker chemistry, conjugation strategies, and degradation mechanisms for bioconjugates.
  • Exposure to regulatory bioanalytical guidance (FDA, EMA) for large molecules and conjugates.

Requirements
  • Ph.D. with 5+ years or M.S. with 8+ years of relevant industry experience in Bioanalysis, Analytical chemistry, or related field.
  • Deep expertise in LC-MS/MS bioanalysis, including method development, qualification/validation, and troubleshooting for complex modalities.
  • Proven experience with Sciex platforms (e.g., 7600 ZenoTOF, 6500+, 7500) and high-resolution MS.
  • Strong background in ADCs, DACs, or related bioconjugates, including characterization and payload quantitation.
  • Experience supporting both in vitro ADME and in vivo PK studies, with demonstrated ability to interpret integrated datasets.
  • Proficiency in sample preparation techniques for large molecules and bioconjugates (e.g., immunocapture, enzymatic digestion, hybrid workflows).
  • Strong data analysis, visualization, and reporting skills (e.g., vendor software, GraphPad Prism).
  • Excellent written and verbal communication skills, with experience in technical documentation.
  • Ability to work in a fast-paced, collaborative environment and manage multiple priorities.

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

Application Process

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Scientist, Bioanalytical - Drug Antibody Conjugates (DACs) jobs: